Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...
July 13 is a special date for Helen Demestihas. It's the day of her wedding anniversary and her diagnosis date. On this day in 2024, as she and her husband celebrated 19 years together, Demestihas ...
March 25, 2026 — A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) ...
In 2019, Jennifer Lava had just moved to Washington, D.C., to start a new job and chapter. The New Jersey native, then 34, had a remarkably normal life and an unremarkable medical history. "I had been ...
Immune checkpoint inhibitors (ICIs) have fundamentally transformed the treatment landscape for localized colorectal cancer (CRC), particularly for the mismatch repair-deficient (dMMR) or ...
Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent) to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results